×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [24]
西北高原生物研究所 [10]
中国科学院大学 [3]
南华大学 [2]
厦门大学 [2]
北京大学 [2]
更多...
内容类型
期刊论文 [56]
学位论文 [3]
专利 [1]
发表日期
2022 [1]
2020 [4]
2019 [1]
2018 [3]
2017 [1]
2016 [3]
更多...
学科主题
Biochemist... [1]
Obstetrics... [1]
Oncology [1]
Toxicology [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共60条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
Construction of a novel bispecific fusion protein to enhance targeting for pancreatic cancer imaging
期刊论文
BIOMATERIALS, 2020, 期号: 255, 页码: 120161
作者:
Wang, Qian
;
Yan, Hao
;
Wang, Zihua
;
Li, Zhangfu
;
Li, Dan
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2020/09/07
Bispecific targeting
Fusion protein
Antibody
Molecular imaging
Pancreatic cancer
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
期刊论文
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
作者:
Jiang, Zongru
;
Wang, Li
;
Liu, Xuesong
;
Chen, Cheng
;
Wang, Beilei
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2020/11/26
Cancer
VEGFR2 kinase
Kinase inhibitor
Angiogenesis
Inhibitor selectivity
Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC
期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11, 期号: 1, 页码: 241-250
作者:
Zhang, Yan
;
Yang, Xinying
;
Liu, Hongchun
;
Cai, Minghui
;
Yang Shentu
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2020/07/01
EGFR-TKIs
NSCLC
lymphangiogenesis
JAK/STAT3
LYVE-1
Polyphotosensitizer nanogels for GSH-responsive histone deacetylase inhibitors delivery and enhanced cancer photodynamic therapy
期刊论文
Colloids and Surfaces B-Biointerfaces, 2020, 卷号: 188, 页码: 11
作者:
N. Liu,H. S. Liu,H. R. Chen,G. Wang,H. L. Teng and Y. L. Chang
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2021/07/06
A Guanidine-Based Synthetic Compound Suppresses Angiogenesis via Inhibition of Acid Ceramidase
期刊论文
ACS CHEMICAL BIOLOGY, 2019, 卷号: 14, 期号: 1, 页码: 11-19
作者:
Cho, Sung Min
;
Lee, Hyung Keun
;
Liu, Qing
;
Wang, Ming-Wei
;
Kwon, Ho Jeong
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2020/07/01
PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis
期刊论文
BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140
作者:
Fang, Xiaona
;
Xie, Hua
;
Luo, Min
;
Chen, Zhen
;
Wang, Fang
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/01/08
Angiogenesis
And-tumor activity
Multi-tyrosine kinases inhibitor
PBA2
VEGFR2
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor
期刊论文
CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219
作者:
Xie, Chengying
;
Wan, Xiaozhe
;
Quan, Haitian
;
Zheng, Mingyue
;
Fu, Li
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2019/01/08
angiogenesis
anlotinib
tyrosine kinase inhibitor
VEGF
VEGFR2
A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma
期刊论文
THERANOSTICS, 2018, 卷号: 8, 期号: 12, 页码: 3256-3267
作者:
Sun, Jingya
;
Wang, Xin
;
Tang, Boyun
;
Liu, Hongchun
;
Zhang, Minmin
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2019/01/08
dasatinib
YAP
Src
renal cell carcinoma
Nanosecond Pulsed Electric Fields Enhance the Anti-tumour Effects of the mTOR Inhibitor Everolimus against Melanoma
期刊论文
SCIENTIFIC REPORTS, 2017
Dai, Jie
;
Wu, Shan
;
Kong, Yan
;
Chi, Zhihong
;
Si, Lu
;
Sheng, Xinan
;
Cui, Chuanliang
;
Fang, Jing
;
Zhang, Jue
;
Guo, Jun
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2017/12/03
ANTICANCER AGENTS
SIGNALING PATHWAY
INDUCE APOPTOSIS
CELL CARCINOMA
CANCER-THERAPY
JURKAT CELLS
PHASE-II
CALCIUM
DEATH
TRIAL
©版权所有 ©2017 CSpace - Powered by
CSpace